Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RDNT · against 202 other Healthcare companies of similar size
Ranked #104 of 203 · scores higher than 49% of peers
Bars: peers in each 10-point band of the growth score22 peers with a growth score of 50–59, including RDNT · Click a bar to see the companies
A mix: stronger revenue growth and 3-year revenue growth, but weaker earnings per share growth than most Healthcare peers.
| Metric | RDNT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 202 reported | 18.9% | 9.7% | 72% | 33% | |
| Earnings per share growthHigher is better · 138 reported | Not reported | 9.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 195 reported | 14.1% | 9.5% | 66% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.8B USD | 99 | 31 | |
| 3 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 3 | 3.8B USD | 98 | 71 | |
| 3 | 9.3B USD | 98 | 64 | |
| 100 | 47.8B HKD (≈$6.1B) | 59 | 58 | |
| 100 | 427.8B JPY (≈$2.9B) | 59 | 52 | |
| 102 | 5.0B USD | 58 | 60 | |
| 103 | 7.2B USD | 57 | 43 | |
| 104 | 5.8B USD | 56 | 38 | |
| 104 | 62.5B SEK (≈$6.3B) | 56 | 60 | |
| 106 | 47.8B HKD (≈$6.1B) | 55 | 60 | |
| 106 | 321.5B INR (≈$3.9B) | 55 | 70 | |
| 108 | 1.09T JPY (≈$7.4B) | 54 | 75 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score